Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

Esophageal cancer other imaging findings

Introduction

Overview

Overview

Other imaging studies for esophageal cancer include positron emission tomography scanning with 18-fluorodeoxyglucose (FDG-PET). FDG-PET is a noninvasive staging modality that is more sensitive than CT or EUS for the detection of distant metastases.

Other Imaging Studies

Other Imaging Studies

FDG-PET

  • FDG-PET is a noninvasive staging modality that is more sensitive than CT or EUS for the detection of distant metastases.[1][2][3]
  • In 20% of cases, management of esophageal cancer was changed after being scanned with FDG-PET.[2]
  • FDG-PET siginificantly improves the detection of stage IV esophageal cancer.
References

References

  1. ↑ van Vliet EP, Heijenbrok-Kal MH, Hunink MG, Kuipers EJ, Siersema PD (2008). “Staging investigations for oesophageal cancer: a meta-analysis”. Br. J. Cancer. 98 (3): 547–57. doi:10.1038/sj.bjc.6604200. PMC 2243147. PMID 18212745.
  2. ↑ 2.0 2.1 Flamen P, Lerut A, Van Cutsem E, De Wever W, Peeters M, Stroobants S, Dupont P, Bormans G, Hiele M, De Leyn P, Van Raemdonck D, Coosemans W, Ectors N, Haustermans K, Mortelmans L (2000). “Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma”. J. Clin. Oncol. 18 (18): 3202–10. doi:10.1200/JCO.2000.18.18.3202. PMID 10986052.
  3. ↑ Flanagan FL, Dehdashti F, Siegel BA, Trask DD, Sundaresan SR, Patterson GA, Cooper JD (1997). “Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography”. AJR Am J Roentgenol. 168 (2): 417–24. doi:10.2214/ajr.168.2.9016218. PMID 9016218.


Template:WikiDoc Sources

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]